Peripheral Histamine 1 Receptor Blockade in IBS: Multicenter Trial
NCT01908465
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
200
Enrollment
OTHER
Sponsor class
Conditions
Irritable Bowel Syndrome (IBS)
Interventions
DRUG:
Ebastine
DRUG:
Placebo
Sponsor
KU Leuven